Human thiopurine S-methyltransferase (TPMT) pharmacogenetics: Variant allozyme aggresome formation.

被引：1
|
作者：
Wang, L [1 ]
Weinshilboum, R [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.257
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P95 / P95
页数：1
相关论文
共 50 条
  • [1] Human thiopurine S-methyltransferase pharmacogenetics:: Variant allozyme misfolding and aggresome formation
    Wang, LW
    Nguyen, TV
    McLaughlin, RW
    Sikkink, LA
    Ramirez-Alvarado, M
    Weinshilboum, RM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (26) : 9394 - 9399
  • [2] Thiopurine S-methyltransferase (TPMT) pharmacogenetics: Role of chaperone proteins in variant allozyme degradation.
    Wang, L
    Sullivan, W
    Toft, D
    Weinshilboum, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P29 - P29
  • [3] Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation
    Li, Fang
    Wang, Liewei
    Burgess, Rebecca J.
    Weinshilboum, Richard M.
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (12): : 1083 - 1094
  • [4] Thiopurine S-methyltransferase (TPMT) pharmacogenetics: Variant allele functional genomics.
    Salavaggione, OE
    Wiepert, M
    Weinshilboum, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P19 - P19
  • [5] Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme
    Feng, Qiping
    Vannaprasaht, Suda
    Peng, Yi
    Angsuthum, Susothorn
    Avihingsanon, Yingyos
    Yee, Vivien C.
    Tassaneeyakul, Wichittra
    Weinshilboum, Richard M.
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (07) : 1053 - 1061
  • [6] Canine thiopurine S-methyltransferase (TPMT): Companion animal pharmacogenetics.
    Salavagione, OE
    Kidd, L
    Prondzinsky, J
    Szumlanski, C
    Wang, L
    Pankratz, V
    Trepanier, L
    Weinshilboum, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P35 - P35
  • [7] Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation
    Wang, LW
    Sullivan, W
    Toft, D
    Weinshilboum, R
    PHARMACOGENETICS, 2003, 13 (09): : 555 - 564
  • [8] Pharmacogenetics of thiopurine S-Methyltransferase and thiopurine therapy
    Evans, WE
    THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 186 - 191
  • [9] Novel thiopurine S-methyltransferase (TPMT) variant identified in Malay individuals
    Lee, Chun Kiat
    Huan, Pei Tee
    Chai, Chean Nee
    Ng, Li Jie
    Koay, Evelyn Siew-Chuan
    Lee, Ogestelli Fabia
    Tan, Malcolm
    Loh, Tze Ping
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (11) : e247 - e250
  • [10] Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics
    Salavaggione, OE
    Wang, LW
    Wiepert, M
    Yee, VC
    Weinshilboum, RM
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (11): : 801 - 815
12345